• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Shionogi joins the Cambridge Therapeutics Consortium

Shionogi joins the Cambridge Therapeutics Consortium

February 16, 2016
CenterWatch Staff

Shionogi has joined the Cambridge Therapeutics Consortium. Launched in July 2015, the consortium links the intellectual know-how of several world renowned academic institutions with the drug developing potential of the pharmaceutical industry.

The consortium unites the world leading research potential of the University of Cambridge and its partner institutions, the Babraham Institute and the Wellcome Trust Sanger Institute, with pharmaceutical companies Astex Pharmaceuticals, AstraZeneca, GlaxoSmithKline and Shionogi. The overarching aim for this innovative partnership model is to study and develop precision medicines for some of the most globally devastating diseases.

Researchers at the University of Cambridge (U.K.) and its partner institutions can access novel therapeutic agents (including small molecules and antibodies) across the entire portfolio of drugs being developed by each of the participating companies, enabling them to investigate their mechanism, efficacy and potential. The terms of the consortium allow researchers to access and share information quickly and easily. Funding is provided for joint research projects and the results of these collaborative projects will lead to joint publications supporting a culture of open innovation and partnership.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing